Cowen - 13 Year Stock Price History Chart | COWN

Historical daily share price chart and data for Cowen since 2006 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Graph 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Cowen as of March 25, 2019 is 14.39.
Cowen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 15.3386 13.9800 16.9900 13.7200 14.3900 7.87%
2018 14.7245 14.0500 17.6600 12.0000 13.3400 -2.27%
2017 15.2720 15.3000 17.9500 12.6500 13.6500 -11.94%
2016 13.5815 14.9600 16.6500 10.4400 15.5000 1.17%
2015 20.5439 18.8000 26.1200 15.2800 15.3200 -20.21%
2014 16.4930 15.4000 19.2000 14.4800 19.2000 22.76%
2013 12.6810 9.9600 16.4000 9.6800 15.6400 59.59%
2012 10.3829 10.4800 11.6000 8.7600 9.8000 -5.41%
2011 14.4620 19.6000 19.9600 9.6400 10.3600 -44.78%
2010 18.1242 23.8800 23.8800 12.1200 18.7600 -20.78%
2009 25.1225 27.2000 34.7600 14.3600 23.6800 -6.92%
2008 30.2131 37.2400 43.2400 19.6400 25.4400 -33.12%
2007 62.8661 82.4000 84.9600 38.0400 38.0400 -55.04%
Sector Industry Market Cap Revenue
Finance Finance - Investment Banks $0.424B $0.967B
COWEN GROUP, INC., through its operating subsidiaries, provides investment banking, equity research, sales and trading, asset management and alternative asset management services to companies and institutional investor clients in the healthcare, technology, telecommunications, aerospace and defense, consumer and alternative energy sectors. Cowen's asset management business includes teams based in the U.S. and the U.K. Cowen's U.S. team focuses on a growth-oriented investment style centered on small and mid-sized companies based primarily in North America. Cowen's U.K. team provides traditional asset management products, focusing on a global equity strategy. Cowen's alternative asset management business consists of Cowen Healthcare Royalty Partners, which invests principally in commercial-stage biopharmaceutical products and companies, and Cowen Capital Partners, which manages a portfolio of middle market private equity investments for third party investors.
Stock Name Country Market Cap PE Ratio
Morgan Stanley (MS) United States $70.487B 8.87
Goldman Sachs (GS) United States $69.139B 7.47
Charles Schwab (SCHW) United States $55.755B 17.07
TD Ameritrade Holding (AMTD) United States $27.670B 13.51
Interactive Brokers (IBKR) United States $20.627B 21.77
Nomura Holdings Inc ADR (NMR) Japan $12.245B 0.00
E*TRADE Financial (ETFC) United States $11.106B 11.59
Raymond James Financial (RJF) United States $10.861B 11.58
LPL Financial Holdings (LPLA) United States $5.726B 13.24
Stifel Financial (SF) United States $3.651B 9.60
Evercore Inc (EVR) United States $3.610B 9.86
Moelis (MC) United States $2.268B 14.35
BGC Partners (BGCP) United States $1.773B 4.45
WisdomTree Investments (WETF) United States $1.084B 21.84
Piper Jaffray (PJC) United States $1.040B 11.55
INTL FCStone (INTL) United States $0.750B 9.50
Diamond Hill Investment (DHIL) United States $0.471B 9.71
Yintech Investment Holdings (YIN) China $0.456B 0.00
Greenhill (GHL) United States $0.451B 12.74
Ladenburg Thalmann Financial Services Inc (LTS) United States $0.413B 0.00
Oppenheimer Holdings (OPY) United States $0.335B 9.34
Siebert Financial (SIEB) United States $0.334B 0.00
Arlington Asset Investment Corp (AI) United States $0.250B 0.00
GAIN Capital Holdings (GCAP) United States $0.237B 9.77
JMP Group LLC (JMP) United States $0.086B 13.90
National Holdings (NHLD) United States $0.038B 0.00
Takung Art (TKAT) China $0.008B 0.00